z-logo
Premium
Obstetricians' views on the ethics of cardiac surgery for newborns with common aneuploidies
Author(s) -
Fruhman Gary,
Miller Collin,
Amon Erol,
Raible Darbey,
Bradshaw Rachael,
Martin Kimberly
Publication year - 2018
Publication title -
prenatal diagnosis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.956
H-Index - 97
eISSN - 1097-0223
pISSN - 0197-3851
DOI - 10.1002/pd.5225
Subject(s) - trisomy , medicine , down syndrome , cardiac surgery , turner syndrome , family medicine , pediatrics , obstetrics , surgery , psychiatry , genetics , biology
Objective To examine whether obstetricians think that cardiac surgery is ethical in babies with common aneuploidies and whether insurance companies should be required to pay for these surgeries. Study Design A survey was e‐mailed to 2897 OB‐GYNs, and 898 (31%) actively practicing obstetricians responded to the survey. Respondents were asked whether it is ethical to offer cardiac surgery for babies with heart defects diagnosed with trisomies 21, 18, and 13 and Turner syndrome and whether insurance companies should be required to pay for such surgeries in cases of trisomy 18 or 13. Chi‐square tests were utilized to compare responses by using an alpha level of .05. Results Most obstetricians thought that offering cardiac surgery was ethical if the baby had trisomy 21 or Turner syndrome (94%), but not trisomy 18 or 13 (75%). Most obstetricians (69%) thought that insurance companies should not be legally required to pay for cardiac surgery for the latter group. Conclusion Obstetricians were more likely to think cardiac surgery was ethical if the prognosis or the outcome was good. Most respondents did not think that insurance companies should be required to subsidize the cost of cardiac surgeries for all babies with trisomy 18 or 13.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here